483 Merck Sharp & Dohme Oct 2001

483 Merck Sharp & Dohme Oct 2001

Lisa Bellows FDA, Kristen Evans FDA, Michael Gurbarg FDA, David Hafner FDA, Debra Pagano FDA, Robert Shibuya FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - West Point, PA, United States facility and issued inspectional observations (via FDA 483) on 29 Oct 2001.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Oct 2001
  • Location: West Point, United States
  • FEI: 2510592
Add To Cart